Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (TCTR20261009001) titled 'Bioequivalence study comparing VINLAZINE 75 (Venlafaxine 75 mg extended-release capsules) and EFEXOR XR in healthy adults under fasting condition' on Oct. 9.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: The Government Pharmaceutical Organization
Condition:
Healthy male and female subjects
Healthy volunteers, Bioequivalence, Venlafaxine 75 mg extended-release capsules Fasting
Healthy volunteers, Bioequivalence, Venlafaxine 75 mg extended-release capsules Fasting
Intervention:
Each extended-release capsule contains venlafaxine hydrochloride equivalent to 75 mg of venlafaxine.,Each ext...